Monitor for any late-breaking activist or dissident filings ahead of the December 17 meeting; the absence of any contested items suggests a routine vote. The next key event is the filing of voting results on Form 8-K within four business days after the meeting.
Price Chart
Executive Summary
Incannex Healthcare Inc. filed a DEFA14A (definitive additional proxy materials) alongside its DEF 14A proxy statement for the 2026 annual meeting. The filings set the annual meeting for December 17, 2026, with proposals to elect two Class III directors (Joel Latham and Troy Valentine) and ratify Grant Thornton as auditor. No dissident or activist campaign is disclosed; the DEFA14A appears to be a routine additional soliciting communication supporting management's proposals.
Key Financial Metrics
Key Facts
- Annual meeting scheduled for December 17, 2026, held virtually.
- Stockholders to vote on election of two Class III directors (Joel Latham and Troy Valentine) and ratification of Grant Thornton Audit Pty Ltd as independent auditor.
- Record date for voting is October 22, 2026; 12,544,627 shares outstanding and entitled to vote.
- Board recommends a vote FOR both proposals.
- No dissident or activist solicitation materials are present; the DEFA14A is filed by the registrant (management).
Financial Impact
No material financial impact from this routine proxy solicitation.
Risk Factors
- No material risks identified from these routine proxy filings.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (IXHL), Batch item 1 | 0001213900-26-113004 |
| Document: 0001213900-26-113004-index-headers.html | 0001213900-26-113003 |
| Document: 0001213900-26-113004-index.html | 0001213900-26-113004 |
| Document: 0001213900-26-113004.txt | 0001213900-26-113004 |
| DEF 14A Filing (IXHL), Batch item 5 | 0001213900-26-113003 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 1d ago | DEFA14A / DEF 14A | $2.62 | awaiting T+20 | awaiting T+20 | $2.71 (+3.44%) |
Sep 9, 2026 7w ago | 8-K | $3.23 $3.18 | ▼ −1.55% | ▼ −3.49% | $2.71 (−16.10%) |
Aug 25, 2026 9w ago | 8-K | $3.75 $3.45 | ▼ −8.13% | ▼ −9.11% | $2.71 (−27.73%) |
Aug 11, 2026 11w ago | 8-K | $3.20 $3.23 | ▲ +0.94% | ▲ +2.00% | $2.71 (−15.31%) |
Jul 23, 2026 14w ago | Press Release | $3.16 $3.62 | ▲ +14.56% | ▲ +11.25% | $2.71 (−14.24%) |
Jul 23, 2026 14w ago | 8-K | $3.16 $3.62 | ▲ +14.56% | ▲ +11.25% | $2.71 (−14.24%) |
Jun 10, 2026 20w ago | Press Release | $3.91 $3.37 | ▼ −13.81% | ▼ −17.43% | $2.71 (−30.69%) |
Jun 10, 2026 20w ago | 8-K | $3.91 $3.37 | ▼ −13.81% | ▼ −17.43% | $2.71 (−30.69%) |
Jun 9, 2026 20w ago | 8-K | $3.67 $3.71 | ▲ +1.09% | ▼ −0.36% | $2.71 (−26.16%) |
May 14, 2026 24w ago | Press Release | $3.88 $3.83 | ▼ −1.29% | ▼ −0.43% | $2.71 (−30.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers